BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11348415)

  • 1. Clinical and pathologic features of breast cancers in women treated for Hodgkin's disease: a case-control study.
    Janov AJ; Tulecke M; O'Neill A; Lester S; Mauch PM; Harris J; Schnitt SJ; Shapiro CL
    Breast J; 2001; 7(1):46-52. PubMed ID: 11348415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of breast cancer after Hodgkin's disease.
    Wolden SL; Hancock SL; Carlson RW; Goffinet DR; Jeffrey SS; Hoppe RT
    J Clin Oncol; 2000 Feb; 18(4):765-72. PubMed ID: 10673517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of breast cancer after Hodgkin's lymphoma and paediatric cancer.
    Terenziani M; Massimino M; Magazzù D; Gandola L; Capri G; Carcangiu ML; Catania S; Di Russo A; Gennaro M; Meazza C; Podda M; Schiavello E; Valagussa P
    Eur J Cancer; 2015 Sep; 51(13):1667-74. PubMed ID: 26092639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.
    Gaffney DK; Hemmersmeier J; Holden J; Marshall J; Smith LM; Avizonis V; Tran T; Neuhausen SL
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):539-46. PubMed ID: 11173152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course of thoracic cancers in Hodgkin's disease survivors.
    Das P; Ng AK; Stevenson MA; Mauch PM
    Ann Oncol; 2005 May; 16(5):793-7. PubMed ID: 15802277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter.
    Alm El-Din MA; Hughes KS; Finkelstein DM; Betts KA; Yock TI; Tarbell NJ; Aisenberg AC; Taghian AG
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):69-74. PubMed ID: 18538497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer after treatment of Hodgkin's disease.
    Hancock SL; Tucker MA; Hoppe RT
    J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer occurred after Hodgkin's disease: clinico-pathological features, treatments and outcome: analysis of 214 cases.
    Cutuli B; Kanoun S; Tunon De Lara C; Baron M; Livi L; Levy C; Cohen-Solal-Lenir C; Lesur A; Kerbrat P; Provencio M; Gonzague-Casabianca L; Mege A; Lemanski C; Delva C; Lancrenon S; Velten M
    Crit Rev Oncol Hematol; 2012 Jan; 81(1):29-37. PubMed ID: 21333547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
    Salloum E; Doria R; Schubert W; Zelterman D; Holford T; Roberts KB; Farber LR; Kiehl RK; Cardinale J; Cooper DL
    J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
    Bhatia S; Robison LL; Oberlin O; Greenberg M; Bunin G; Fossati-Bellani F; Meadows AT
    N Engl J Med; 1996 Mar; 334(12):745-51. PubMed ID: 8592547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases].
    Cutuli B; de La Rochefordière A; Dhermain F; Borel C; Graic Y; de Lafontan B; Dilhyudy JM; Mignotte H; Tessier E; Tortochaux J; N'Guyen T; Bey P; Le Mevel-Le Pourhier A; Arriagada R
    Cancer Radiother; 1997; 1(4):300-6. PubMed ID: 9435820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
    J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis.
    Alm El-Din MA; Hughes KS; Raad RA; Goldberg SI; Aisenberg AC; Niemierko A; Taghian AG
    Radiat Oncol; 2009 Jun; 4():19. PubMed ID: 19566943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer in women after treatment for Hodgkin's disease.
    Deniz K; O'Mahony S; Ross G; Purushotham A
    Lancet Oncol; 2003 Apr; 4(4):207-14. PubMed ID: 12681264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases.
    Cutuli B; Borel C; Dhermain F; Magrini SM; Wasserman TH; Bogart JA; Provencio M; de Lafontan B; de la Rochefordiere A; Cellai E; Graic Y; Kerbrat P; Alzieu C; Teissier E; Dilhuydy JM; Mignotte H; Velten M
    Radiother Oncol; 2001 Jun; 59(3):247-55. PubMed ID: 11369065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of second cancers in patients treated for Hodgkin's disease.
    Boivin JF; Hutchison GB; Zauber AG; Bernstein L; Davis FG; Michel RP; Zanke B; Tan CT; Fuller LM; Mauch P
    J Natl Cancer Inst; 1995 May; 87(10):732-41. PubMed ID: 7563150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.